The role of CD39 in CRC progression and metastasis was investigated in CD39+/− mice, CD39+/+ mice, or over-expressing CD39 transgenic mice (htCD39) all in a BALB/c background. The gene discussed is ENTPD1; the disease is colorectal carcinoma.